Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00844441 · ClinicalTrials.gov registry record · NA
Early Discharge and Outpatient Care After Chemotherapy in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
A NA study, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 96
- Enrollment target
NCT00844441 is a NA study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 96 participants.
The verdict
NCT00844441, a NA study, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
Study Summary
RATIONALE: Gathering information about patients with myelodysplastic syndrome or acute myeloid leukemia who are discharged after finishing chemotherapy, or who stay in the hospital until blood counts return to normal, may help doctors learn more about a patient's quality of life, use of medical services, and the cost of these services. PURPOSE: This clinical trial is studying early discharge and outpatient care in patients who have undergone chemotherapy for myelodysplastic syndrome or acute myeloid leukemia.
Interventions
- OTHER medical chart review
- OTHER questionnaire administration
- PROCEDURE quality-of-life assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2008-12 |
| Est. Completion | 2011-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00844441
The ClinicalTrials.gov registry entry for NCT00844441 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which medical chart review is the first listed.
NCT00844441 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00844441 about?
NCT00844441 is a clinical study titled "Early Discharge and Outpatient Care After Chemotherapy in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia". RATIONALE: Gathering information about patients with myelodysplastic syndrome or acute myeloid leukemia who are discharged after finishing chemotherapy, or who stay in the hospital until blood counts return to normal, may help doctors learn more about a patient's quality of life, use of medical serv...
What is the current status of trial NCT00844441?
This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2008-12. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00844441?
The interventions under investigation include: medical chart review (OTHER), questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE).
Who is sponsoring clinical trial NCT00844441?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.